CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: gabapentin
Accession: CHEBI:42797
browse the term
Definition: A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Synonyms: exact_synonym: [1-(aminomethyl)cyclohexyl]acetic acid
related_synonym: 1-(Aminomethyl)cyclohexaneacetic acid; Formula=C9H17NO2; InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12); InChIKey=UGJMXCAKCUNAIE-UHFFFAOYSA-N; Neurontin; SMILES=NCC1(CCCCC1)CC(O)=O; gabapentina; gabapentine; gabapentinum
alt_id: CHEBI:5237
xref: Beilstein:2359739; CAS:60142-96-3; DrugBank:DB00996; Drug_Central:1264; HMDB:HMDB0005015; KEGG:D00332; LINCS:LSM-5716
xref_mesh: MESH:C040029
xref: PDBeChem:GBN; PMID:22048285; PMID:22144034; PMID:22240839; PMID:22240859; PMID:22279347; PMID:22296650; PMID:22345405; PMID:22352861; PMID:22419014; PMID:22422817; PMID:22464746; PMID:22467888; PMID:22556282; PMID:22575516; PMID:22612015; PMID:22865488; PMID:22888801; PMID:22934077; PMID:22946876; PMID:23018586; PMID:23053645; Patent:EP1140793; Patent:US2008103334; Patent:US2008269326; Patent:US2009043126; Patent:US2009292138; Patent:US2012046272; Patent:WO2005037784; Patent:WO2008060572; Patent:WO2010023694; Reaxys:2359739; VSDB:2975; Wikipedia:Gabapentin
G
AADAT
aminoadipate aminotransferase
decreases activity
ISO
gabapentin results in decreased activity of AADAT protein
CTD
PMID:16765940
NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699
G
ABCB1
ATP binding cassette subfamily B member 1
decreases activity
EXP
gabapentin results in decreased activity of ABCB1 protein
CTD
PMID:18408562
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
AKR7A3
aldo-keto reductase family 7 member A3
increases expression
ISO
gabapentin results in increased expression of AKR7A3 mRNA
CTD
PMID:17381134
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
G
CACNA1A
calcium voltage-gated channel subunit alpha1 A
decreases activity multiple interactions
ISO
gabapentin results in decreased activity of CACNA1A protein gabapentin promotes the reaction [[omega-Agatoxin IVA results in decreased activity of CACNA1A protein] which results in decreased susceptibility to Potassium Chloride]
CTD
PMID:12770949 PMID:12817894
NCBI chr19:13,206,442...13,506,479
Ensembl chr19:13,206,442...13,624,489
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
decreases activity
ISO
gabapentin results in decreased activity of CACNA1B protein
CTD
PMID:12770949
NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
multiple interactions
ISO
CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]]; gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]; gabapentin affects the reaction [[CACNA1D protein co-treated with CACNB3 protein] results in increased transport of Calcium]
CTD
PMID:19796812
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
G
CACNA2D1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
affects binding multiple interactions
ISO
gabapentin binds to CACNA2D1 protein CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]] [gabapentin binds to and results in decreased activity of CACNA2D1 protein] which results in decreased susceptibility to Methamphetamine; [gabapentin binds to and results in decreased activity of CACNA2D1 protein] which results in decreased susceptibility to Potassium Chloride; [gabapentin results in decreased activity of CACNA2D1 protein] inhibits the reaction [Potassium Chloride results in increased transport of Calcium]; gabapentin inhibits the reaction [Methamphetamine results in increased expression of CACNA2D1 mRNA]
CTD
PMID:16380257 PMID:17442347 PMID:17881535 PMID:19796812 PMID:20340177 PMID:21182903 More...
NCBI chr 7:81,946,444...82,443,956
Ensembl chr 7:81,946,444...82,443,956
G
CACNA2D2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
affects activity affects binding
ISO EXP
CACNA2D2 protein affects the activity of gabapentin gabapentin binds to CACNA2D2 protein
CTD
PMID:11687876 PMID:14660671
NCBI chr 3:50,362,613...50,504,244
Ensembl chr 3:50,362,613...50,504,244
G
CACNB3
calcium voltage-gated channel auxiliary subunit beta 3
multiple interactions
ISO
CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]]; gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]; gabapentin affects the reaction [[CACNA1D protein co-treated with CACNB3 protein] results in increased transport of Calcium]
CTD
PMID:19796812
NCBI chr12:48,814,480...48,828,941
Ensembl chr12:48,813,794...48,828,941
G
CP
ceruloplasmin
decreases expression
ISO
gabapentin results in decreased expression of CP mRNA
CTD
PMID:17381134
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
decreases expression
ISO
gabapentin results in decreased expression of CYP1A1 mRNA
CTD
PMID:17381134
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
decreases expression
ISO
gabapentin results in decreased expression of CYP2E1 mRNA
CTD
PMID:17381134
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP4A22
cytochrome P450 family 4 subfamily A member 22
decreases expression
ISO
gabapentin results in decreased expression of CYP4A1 mRNA
CTD
PMID:17381134
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
G
DLG4
discs large MAGUK scaffold protein 4
multiple interactions
ISO
Gabapentin inhibits the reaction [monobutyl phthalate results in increased expression of DLG4 protein]
CTD
PMID:35278568
NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836
G
F10
coagulation factor X
decreases expression
ISO
gabapentin results in decreased expression of F10 mRNA
CTD
PMID:17381134
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
Gabapentin results in decreased expression of G6PC1 mRNA
CTD
PMID:17381134
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GABBR1
gamma-aminobutyric acid type B receptor subunit 1
multiple interactions
EXP
CGP 71872 inhibits the reaction [gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]]; gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]
CTD
PMID:11125035
NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
G
GABBR2
gamma-aminobutyric acid type B receptor subunit 2
multiple interactions
EXP
CGP 71872 inhibits the reaction [gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]]; gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]
CTD
PMID:11125035
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
EXP
Gabapentin results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
G
GSTA2
glutathione S-transferase alpha 2
decreases expression
ISO
gabapentin results in decreased expression of GSTA2 mRNA
CTD
PMID:17381134
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTM1
glutathione S-transferase mu 1
increases expression
ISO
gabapentin results in increased expression of GSTM1 mRNA
CTD
PMID:17381134
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
HMOX1
heme oxygenase 1
increases expression
ISO
gabapentin results in increased expression of HMOX1 mRNA
CTD
PMID:17381134
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
decreases expression
ISO
gabapentin results in decreased expression of HSP90AA1 mRNA
CTD
PMID:17381134
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
IGF1
insulin like growth factor 1
increases expression
ISO
gabapentin results in increased expression of IGF1 mRNA
CTD
PMID:17381134
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
KCNH2
potassium voltage-gated channel subfamily H member 2
decreases activity
EXP
gabapentin results in decreased activity of KCNH2 protein
CTD
PMID:15716081
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
KYAT1
kynurenine aminotransferase 1
decreases activity
ISO
gabapentin results in decreased activity of KYAT1 protein
CTD
PMID:16765940
NCBI chr 9:128,832,942...128,882,523
Ensembl chr 9:128,832,942...128,882,494 Ensembl chr 9:128,832,942...128,882,494
G
LPO
lactoperoxidase
decreases expression
EXP
Gabapentin results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr17:58,238,584...58,268,518
Ensembl chr17:58,218,548...58,268,518
G
MTOR
mechanistic target of rapamycin kinase
decreases expression
EXP
Gabapentin results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
NCL
nucleolin
increases expression
ISO
gabapentin results in increased expression of NCL mRNA
CTD
PMID:17381134
NCBI chr 2:231,453,531...231,464,484
Ensembl chr 2:231,453,531...231,483,641
G
NOS2
nitric oxide synthase 2
increases expression
ISO
gabapentin results in increased expression of NOS2 protein
CTD
PMID:14511393
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
gabapentin results in increased expression of NQO1 mRNA
CTD
PMID:17381134
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
PNOC
prepronociceptin
decreases expression
ISO
gabapentin results in decreased expression of PNOC mRNA
CTD
PMID:18281898
NCBI chr 8:28,316,988...28,343,351
Ensembl chr 8:28,316,986...28,343,355
G
PON1
paraoxonase 1
decreases activity
EXP
gabapentin results in decreased activity of PON1 protein
CTD
PMID:28032682
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
SHANK2
SH3 and multiple ankyrin repeat domains 2
decreases expression
EXP
Gabapentin results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
G
SLC22A7
solute carrier family 22 member 7
increases expression decreases expression
ISO
gabapentin results in increased expression of SLC22A7 mRNA gabapentin results in decreased expression of SLC22A7 mRNA
CTD
PMID:17381134
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SLC6A4
solute carrier family 6 member 4
decreases expression
EXP
Gabapentin results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SLC7A5
solute carrier family 7 member 5
increases import
EXP
SLC7A5 protein results in increased import of gabapentin
CTD
PMID:27818298
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
ST13
ST13 Hsp70 interacting protein
increases expression
ISO
gabapentin results in increased expression of ST13 mRNA
CTD
PMID:17381134
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
SULT1A1
sulfotransferase family 1A member 1
decreases expression
ISO
gabapentin results in decreased expression of SULT1A1 mRNA
CTD
PMID:17381134
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
G
SYN1
synapsin I
multiple interactions
ISO
Gabapentin inhibits the reaction [monobutyl phthalate results in increased expression of SYN1 protein]
CTD
PMID:35278568
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
G
TAC1
tachykinin precursor 1
multiple interactions
ISO
gabapentin inhibits the reaction [Freund's Adjuvant promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]
CTD
PMID:14499429
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TKT
transketolase
increases expression
ISO
gabapentin results in increased expression of TKT mRNA
CTD
PMID:17381134
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TXNRD1
thioredoxin reductase 1
increases expression
ISO
gabapentin results in increased expression of TXNRD1 mRNA
CTD
PMID:17381134
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UGDH
UDP-glucose 6-dehydrogenase
decreases expression
ISO
gabapentin results in decreased expression of UGDH mRNA
CTD
PMID:17381134
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases expression
ISO
gabapentin results in increased expression of UGT2B1 mRNA
CTD
PMID:17381134
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all